FAP-targeted [(68)Ga]BED003-PET compared with [(18)F]DOPA-PET in patients with recurrent medullary thyroid carcinoma.
Journal: Frontiers in nuclear medicine
•
Abstract
Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.
Subjects & Keywords
How to Cite this Article
Ventura D, Noto B, Backhaus P, et al. (2026). "FAP-targeted [(68)Ga]BED003-PET compared with [(18)F]DOPA-PET in patients with recurrent medullary thyroid carcinoma.". Frontiers in nuclear medicine. https://doi.org/10.3389/fnume.2026.1949036